Skip to main content
. 2013 Nov 5;8(11):e78532. doi: 10.1371/journal.pone.0078532

Figure 1. Anti-influena IgM-response after influenza-vaccination in IFNβ-treated patients and in healthy controls.

Figure 1

The concentration of anti-influenza A (panel A) and anti-influenza B (panel B) IgM is shown as detected before (day 0) and at day 7, 14 and 28 after influenza vaccination in IFNβ-treated patients with MS (IFNβ) and healthy controls (HC) (mean + SEM). *** indicates p< 0.0001